We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+11.94%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.73B
AUM Growth
+$6.46M
Cap. Flow
-$42.8M
Cap. Flow %
-2.48%
Top 10 Hldgs %
30.81%
Holding
279
New
77
Increased
40
Reduced
47
Closed
83

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$14.4M
2
ILMN icon
Illumina
ILMN
+$11.2M
3
ICUI icon
ICU Medical
ICUI
+$10.4M
4
OLK
Olink Holding AB (publ) American Depositary Shares
OLK
+$9.5M
5
OM icon
Outset Medical
OM
+$8.23M

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$20.5M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$13.9M
3
LUNG icon
Pulmonx
LUNG
+$10.1M
4
NSTG
NanoString Technologies, Inc.
NSTG
+$9.8M
5
EVH icon
Evolent Health
EVH
+$7.06M

Sector Composition

Rank Sector Weight
1 Healthcare 34.81%
2 Industrials 0.32%
3 Materials 0.15%
4 Consumer Staples 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOSS icon
101
Gossamer Bio
GOSS
$86.8M
$4.1M 0.24%
341,878
+261,000
+323% +$3.24M
ESTA icon
102
CALL
Establishment Labs
ESTA
$2.25B
$4.02M 0.23%
+73,600
New +$4.4M
GERN icon
103
CALL
Geron
GERN
$1.01B
$3.98M 0.23%
1,702,600
– –
SNY icon
104
Sanofi
SNY
$105B
$3.71M 0.21%
+97,684
New +$4.35M
ISRG icon
105
Intuitive Surgical
ISRG
$142B
$3.7M 0.21%
+19,732
New +$4.24M
MASI
106
DELISTED
Masimo
MASI
$3.64M 0.21%
+25,800
New +$3.77M
TNDM icon
107
Tandem Diabetes Care
TNDM
$1.63B
$3.59M 0.21%
+75,000
New +$4.11M
AGL icon
108
Agilon Health
AGL
$1.45B
$3.51M 0.2%
6,000
-3,444
-36% -$2.06M
BCRX icon
109
BioCryst Pharmaceuticals
BCRX
$2.71B
$3.49M 0.2%
276,629
-87,623
-24% -$1.13M
TCDA
110
CALL
DELISTED
Tricida, Inc. Common Stock
TCDA
$3.33M 0.19%
318,100
– –
RMD icon
111
ResMed
RMD
$32.8B
$3.27M 0.19%
+15,000
New +$3.41M
NARI
112
PUT
DELISTED
Inari Medical, Inc. Common Stock
NARI
$3.2M 0.18%
+44,000
New +$3.28M
LQDA icon
113
Liquidia Corp
LQDA
$7.01B
$2.93M 0.17%
+537,870
New +$3.02M
TGTX icon
114
PUT
TG Therapeutics
TGTX
$7.58B
$2.92M 0.17%
493,100
+122,100
+33% +$801K
TXG icon
115
PUT
10x Genomics
TXG
$7.52B
$2.85M 0.16%
100,000
-150,000
-60% -$5.71M
ICPT
116
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$2.79M 0.16%
+200,000
New +$3.22M
MRUS
117
DELISTED
Merus
MRUS
$2.72M 0.16%
+135,632
New +$3.24M
AMRS
118
DELISTED
Amyris Inc.
AMRS
$2.56M 0.15%
875,000
-175,399
-17% -$478K
OSH
119
PUT
DELISTED
Oak Street Health, Inc.
OSH
$2.45M 0.14%
+100,000
New +$2.65M
ATAI icon
120
AtaiBeckley Inc
ATAI
$2.68B
$2.39M 0.14%
721,824
– –
RCEL icon
121
CALL
Avita Medical
RCEL
$251M
$2.37M 0.14%
450,000
– –
COR icon
122
PUT
Cencora
COR
$60B
$2.37M 0.14%
17,500
-17,500
-50% -$2.51M
SOPH icon
123
SOPHiA GENETICS
SOPH
$635M
$2.36M 0.14%
896,240
+36,310
+4% +$127K
APEN
124
DELISTED
Apollo Endosurgery, Inc.
APEN
$2.35M 0.14%
427,057
– –
INMD icon
125
PUT
InMode
INMD
$875M
$2.33M 0.13%
80,000
-130,000
-62% -$4.03M
3 4
5
6 7

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q3 2022 Portfolio in Review

As of Q3 2022, Pura Vida Investments held 279 positions worth $1.73B, up 0.38% from $1.72B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Pura Vida Investments's Q3 2022 filing shows 77 new, 40 increased, 47 reduced and 83 closed positions. Its largest new stake was Illumina: 56,540 shares worth $10.5M. The largest sale was Biogen, an estimated $20.5M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Industrials and Materials.

  • Pura Vida Investments's largest Q3 2022 buy was Illumina: 56,540 shares worth $10.5M.
  • Pura Vida Investments added most to United Therapeutics in Q3 2022, an estimated $14.4M increase.
  • Pura Vida Investments's biggest Q3 2022 reduction was Biogen, cutting an estimated $20.5M.
  • Pura Vida Investments fully exited Alnylam Pharmaceuticals in Q3 2022, selling an estimated $13.9M.
  • Pura Vida Investments's ten largest holdings make up 31% of its $1.73B portfolio in Q3 2022.
  • Pura Vida Investments opened 77 new positions and closed 83 in Q3 2022.
  • Pura Vida Investments's portfolio value rose 0.38% quarter-over-quarter to $1.73B.

Based on Pura Vida Investments's 13F filing for Q3 2022, filed 14 Nov 2022.